Bang‐Le Zhang
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- RNA Interference and Gene Delivery 17
- Advanced biosensing and bioanalysis techniques 13
- Natural product bioactivities and synthesis 5
- Biomaterials 22
- Nanoparticle-Based Drug Delivery 17
- Co-authors
- Siyuan Zhou (71 shared papers)Qibing Mei (36 shared papers)Miao Liu (26 shared papers)Daozhou Liu (24 shared papers)Han Cui (15 shared papers)Meng‐Lei Huan (30 shared papers)Ying Cheng (13 shared papers)Ying Cheng (8 shared papers)
- Journals
- Journal of Nanobiotechnology (9 papers)Nanotechnology (7 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)PLoS ONE (4 papers)International Journal of Pharmaceutics (4 papers)
- Partner nations
- ChinaUnited StatesIndia
In The Last Decade
Bang‐Le Zhang
110 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 125
- Biomaterials 458
- Geriatrics and Gerontology 98
- Complementary and alternative medicine 210
- Pharmaceutical Science 112
- Molecular Biology 1.1k
Countries citing papers authored by Bang‐Le Zhang
This map shows the geographic impact of Bang‐Le Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bang‐Le Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bang‐Le Zhang more than expected).
Fields of papers citing papers by Bang‐Le Zhang
This network shows the impact of papers produced by Bang‐Le Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bang‐Le Zhang. The network helps show where Bang‐Le Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Bang‐Le Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 195 | |
| 2 | 2012 | 188 | |
| 3 | 2016 | 168 | |
| 4 | 2013 | 129 | |
| 5 | 2016 | 93 | |
| 6 | 2018 | 73 | |
| 7 | 2019 | 68 | |
| 8 | 2008 | 60 | |
| 9 | 2021 | 58 | |
| 10 | 2018 | 55 | |
| 11 | 2022 | 52 | |
| 12 | 2018 | 50 | |
| 13 | 2022 | 46 | |
| 14 | 2009 | 45 | |
| 15 | 2017 | 45 | |
| 16 | 2015 | 44 | |
| 17 | 2014 | 44 | |
| 18 | 2022 | 43 | |
| 19 | 2022 | 42 | |
| 20 | 2011 | 41 |
About Bang‐Le Zhang
Bang‐Le Zhang is a scholar working on Molecular Biology, Biomaterials, Biomedical Engineering, Oncology and Organic Chemistry, having authored 115 papers that have together received 2.7k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (17 papers), Nanoparticle-Based Drug Delivery (17 papers), Advanced biosensing and bioanalysis techniques (13 papers), Nanoplatforms for cancer theranostics (13 papers), Traditional Chinese Medicine Analysis (7 papers), Inflammatory mediators and NSAID effects (6 papers), Natural product bioactivities and synthesis (5 papers) and Immune cells in cancer (5 papers). The work is most often cited by research in Biomaterials (458 citations), Geriatrics and Gerontology (98 citations), Complementary and alternative medicine (210 citations), Pharmaceutical Science (112 citations) and Molecular Biology (1.1k citations). Bang‐Le Zhang has collaborated with scholars based in China, United States and India. Frequent co-authors include Siyuan Zhou, Qibing Mei, Miao Liu, Daozhou Liu, Han Cui, Meng‐Lei Huan, Ying Cheng, Ying Cheng, Qifeng Ji and Siwang Wang. Their work appears in journals such as Journal of Nanobiotechnology, Nanotechnology, Bioorganic & Medicinal Chemistry Letters, PLoS ONE and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.